These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 17015055

  • 1. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L, Richards S, Cartwright CS, Mitchell C, Lilleyman JS, Vora A, UK MRC/NCRI Childhood Leukaemia Working Party.
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [Abstract] [Full Text] [Related]

  • 2. Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
    Jacobs SS, Stork LC, Bostrom BC, Hutchinson R, Holcenberg J, Reaman GH, Erdmann G, Franklin J, Neglia JP, Steinberg SM, Balis FM, Adamson PC, Children's Oncology Group, National Cancer Institute.
    Pediatr Blood Cancer; 2007 Sep; 49(3):250-5. PubMed ID: 16856155
    [Abstract] [Full Text] [Related]

  • 3. Thiopurine S-methyltransferase (TPMT) gene polymorphism in Brazilian children with acute lymphoblastic leukemia: association with clinical and laboratory data.
    Silva MR, de Oliveira BM, Viana MB, Murao M, Romanha AJ.
    Ther Drug Monit; 2008 Dec; 30(6):700-4. PubMed ID: 19057372
    [Abstract] [Full Text] [Related]

  • 4. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
    Chrzanowska M, Kuehn M, Januszkiewicz-Lewandowska D, Kurzawski M, Droździk M.
    Acta Pol Pharm; 2012 Dec; 69(3):405-10. PubMed ID: 22594254
    [Abstract] [Full Text] [Related]

  • 5. Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia.
    Kapoor G, Sinha R, Naithani R, Chandgothia M.
    Leuk Res; 2010 Aug; 34(8):1023-6. PubMed ID: 20153897
    [Abstract] [Full Text] [Related]

  • 6. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.
    Broxson EH, Dole M, Wong R, Laya BF, Stork L.
    Pediatr Blood Cancer; 2005 Mar; 44(3):226-31. PubMed ID: 15503293
    [Abstract] [Full Text] [Related]

  • 7. Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?
    Fakhoury M, Andreu-Gallien J, Mahr A, Medard Y, Azougagh S, Vilmer E, Jacqz-Aigrain E.
    J Clin Pharm Ther; 2007 Dec; 32(6):633-9. PubMed ID: 18021342
    [Abstract] [Full Text] [Related]

  • 8. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
    Albayrak M, Konyssova U, Kaya Z, Gursel T, Guntekin S, Percin EF, Kocak U.
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026
    [Abstract] [Full Text] [Related]

  • 9. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
    Peregud-Pogorzelski J, Tetera-Rudnicka E, Kurzawski M, Brodkiewicz A, Adrianowska N, Mlynarski W, Januszkiewicz D, Drozdzik M.
    Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
    [Abstract] [Full Text] [Related]

  • 10. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.
    Tumer TB, Ulusoy G, Adali O, Sahin G, Gozdasoglu S, Arinç E.
    Am J Hematol; 2007 Oct; 82(10):906-10. PubMed ID: 17617792
    [Abstract] [Full Text] [Related]

  • 11. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
    Dokmanovic L, Urosevic J, Janic D, Jovanovic N, Petrucev B, Tosic N, Pavlovic S.
    Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
    [Abstract] [Full Text] [Related]

  • 12. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
    Dervieux T, Blanco JG, Krynetski EY, Vanin EF, Roussel MF, Relling MV.
    Cancer Res; 2001 Aug 01; 61(15):5810-6. PubMed ID: 11479220
    [Abstract] [Full Text] [Related]

  • 13. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
    Ravikumara M, Hill FG, Wilson DC, Gillett PM, Thomas A, Brown R, Darbyshire PJ, McKiernan PJ.
    J Pediatr Gastroenterol Nutr; 2006 May 01; 42(5):535-8. PubMed ID: 16707977
    [Abstract] [Full Text] [Related]

  • 14. A cost effectiveness analysis of thiopurine methyltransferase testing for guiding 6-mercaptopurine dosing in children with acute lymphoblastic leukemia.
    Donnan JR, Ungar WJ, Mathews M, Hancock-Howard RL, Rahman P.
    Pediatr Blood Cancer; 2011 Aug 01; 57(2):231-9. PubMed ID: 21344614
    [Abstract] [Full Text] [Related]

  • 15. Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K, Forestier E, Kristinsson J, Söderhäll S, Vettenranta K, Weinshilboum R, Wesenberg F, Nordic Society of Paediatric Haematology and Oncology.
    Leukemia; 2009 Mar 01; 23(3):557-64. PubMed ID: 18987654
    [Abstract] [Full Text] [Related]

  • 16. Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
    Stork LC, Matloub Y, Broxson E, La M, Yanofsky R, Sather H, Hutchinson R, Heerema NA, Sorrell AD, Masterson M, Bleyer A, Gaynon PS.
    Blood; 2010 Apr 08; 115(14):2740-8. PubMed ID: 20124218
    [Abstract] [Full Text] [Related]

  • 17. TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Wray L, Vujkovic M, McWilliams T, Cannon S, Devidas M, Stork L, Aplenc R.
    Pediatr Blood Cancer; 2014 Nov 08; 61(11):2086-8. PubMed ID: 24737678
    [Abstract] [Full Text] [Related]

  • 18. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.
    Stoneham S, Lennard L, Coen P, Lilleyman J, Saha V.
    Br J Haematol; 2003 Oct 08; 123(1):100-2. PubMed ID: 14510948
    [Abstract] [Full Text] [Related]

  • 19. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine.
    Wan Rosalina WR, Teh LK, Mohamad N, Nasir A, Yusoff R, Baba AA, Salleh MZ.
    J Clin Pharm Ther; 2012 Apr 08; 37(2):237-41. PubMed ID: 21545474
    [Abstract] [Full Text] [Related]

  • 20. Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia.
    Lancaster DL, Patel N, Lennard L, Lilleyman JS.
    Cancer Chemother Pharmacol; 2002 Jul 08; 50(1):33-6. PubMed ID: 12111109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.